The Efficacy and Safety of Low-Level Tragus Stimulation on Heart Rate Variability, Neutrophil-Lymphocyte Ratio, and Major Adverse Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction (TESLA-STEMI)

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT06537583

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Universitas Diponegoro (from the registry)
Registry
  • NCT NCT06537583
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Indonesia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06537583. Randomized; single masking; primary purpose treatment. Start 2024-01-01 (actual); primary completion 2024-08-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Efficacy and Safety of Low-Level Tragus Stimulation on Heart Rate Variability, Neutrophil-Lymphocyte Ratio, and Major Adverse Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction (TESLA-STEMI)
Acronym
TESLA-STEMI
Condition
ST Elevation Myocardial Infarction
Intervention (Device)
Parasym Neuromodulation Device (Treatment Group)
Intervention (Device)
Parasym Neuromodulation Device (Sham Group)
Lead sponsor
Universitas Diponegoro (class: other)

Record details

Record id
cardio:ct-nct06537583
Content hash
164a41f2125b10800b15cbb4ba8087b906fe0dd69c216c61e9b73baf17a072dd